Cancer in the News #16: New tests, treatments, and risks for cancers. Fraud and studies to participate in.
4 min readOct 19, 2021
6/6/21: 16th issue: Contents
- Lynparza reduced risk of cancer recurrence by 42% in patients with germline BRCA-mutated high-risk early breast cancer
- Blood Test for 50 Cancers Coming to US Clinics Soon